6 completed, 3 terminated, 2 recruiting, 2 unknown. 13 Phase 2, 7 Phase 1, 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Completed 6, Terminated 3, Recruiting 2, Unknown 2 |
| Phase 1 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Phase 3 | 3 | Completed 1, Terminated 1, Unknown 1 |
Follow TAU: new trials by email Literature Review of TAU trials Research Report on TAU
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Orexin Receptor Antagonism and Sleep in Stimulant Use Disorder SUVO, TAU - Stimulant Use Disorder | Phase 2 | Recruiting | The University of Texas Health Science Center, Houston | 20 | 2024-07-25 | 2025-09-05 |
| Pharmacologic Treatment Augmentation in Chronic Depression Ketamine, Placebo, CBASP - Major Depressive Disorder | Phase 2 | Recruiting | University Hospital Tuebingen | 60 | 2024-04-29 | 2025-03-27 |
| Integrated Digital Intervention for Alcohol Use Disorder Mobile health application, Medical Management - Alcohol Use Disorder | Phase 2 / Phase 3 | Completed | Quit Genius | 242 | 2023-01-01 | 2025-11-20 |
| A Study to Evaluate the Safety and Effectiveness of a Digital Therapeutic OTX-202, OTX-000, Treatment as Usual - Suicide, Attempted, Suicidal Ideation | Phase 2 / Phase 3 | Terminated | Oui Therapeutics, Inc. | 356 | 2022-04-07 | 2025-06-12 |
| Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia Vortioxetine, Usual Antipsychotic Treatment - Cognitive Impairment With Primary Psychotic Disorder, Negative Symptoms With Primary Psychotic Disorder | Phase 2 / Phase 3 | Unknown | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 37 | 2022-01-20 | 2024-02-26 |
| Partner-Assisted Interpersonal Psychotherapy or Antidepressant Medication for Antenatal Depression Partner-Assisted Interpersonal Psychotherapy, Treatment as Usual - Partner Assisted Interpersonal Psychotherapy, Treatment as Usual | Phase 1 / Phase 2 | Terminated | University of North Carolina, Chapel Hill | 2 | 2012-11-01 | 2014-01-14 |
| Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates REVAMP, TAU - Impulsive Behavior, Substance Abuse | Phase 1 / Phase 2 | Unknown | George Mason University | 40 | 2011-04-01 | 2013-05-07 |
| Mindfulness Based Relapse Prevention: Efficacy and Mechanisms Mindfulness Based Relapse Prevention, Relapse Prevention, Treatment as Usual - Substance Use Disorders | Phase 1 / Phase 2 | Completed | University of Washington | 286 | 2009-10-01 | 2016-08-15 |
| Treatment for Non-Suicidal Self-Injury in Young Adults T-SIB, Treatment as usual - Non-suicidal Self-injury | Phase 1 / Phase 2 | Completed | Fordham University | 45 | 2008-09-01 | 2015-03-10 |
| Family Based Treatment of Depressed Adolescents Attachment Based Family therapy (ABFT) - Depressive Disorder, Mood Disorder | Phase 2 | Terminated | Helse Stavanger HF | 20 | 2008-06-01 | 2015-07-31 |
| Virtual Reality (VR) Therapy for Post-Traumatic Stress Disorder (PTSD) Treatment as Usual, Virtual Reality Exposure with Stimulus Control - Post-Traumatic Stress Disorder | Phase 1 / Phase 2 | Completed | Office of Naval Research (ONR) | 136 | 2005-01-01 | 2009-10-09 |
| Transplant and Addiction Project (TAP) - 1 TAP, TAU - End Stage Liver Disease, End Stage Renal Disease | Phase 1 / Phase 2 | Completed | St. Luke's-Roosevelt Hospital Center | 41 | 2003-09-01 | 2015-04-14 |
| Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder Sertraline, Treatment as usual (TAU) - Premenstrual Syndrome | Phase 1 / Phase 2 | Completed | Yale University | 66 | 2001-09-01 | 2016-01-12 |
Depressive Disorder, Major (4) · Substance-Related Disorders (4) · Anxiety Disorders (2) · Depression (2) · Alcoholism (1) · Behavior, Addictive (1) · Depressive Disorder (1) · End Stage Liver Disease (1) · Impulsive Behavior (1) · Kidney Failure, Chronic (1) · Mood Disorders (1) · Premenstrual Syndrome (1) · Self-Injurious Behavior (1) · Stress Disorders, Post-Traumatic (1) · Suicidal Ideation (1)
Fordham University (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1) · George Mason University (1) · Helse Stavanger HF (1) · Office of Naval Research (ONR) (1) · Oui Therapeutics, Inc. (1) · Quit Genius (1) · St. Luke's-Roosevelt Hospital Center (1) · The University of Texas Health Science Center, Houston (1) · University Hospital Tuebingen (1) · University of North Carolina, Chapel Hill (1) · University of Washington (1) · Yale University (1)
United States (10) · Germany (1) · Norway (1) · Spain (1)
Andreas J Fallgatter, Prof. Dr. (1) · Anna R. Brandon, PhD, MSCS (1) · Benedicto Crespo Facorro, Professor (1) · Brenda Wiederhold, PhD (1) · Deborah Haller (1) · Heather Webber, PhD (1) · June P Tangney, PhD (1) · Kimberly A Yonkers, MD (1) · Margaret S Andover, Ph.D. (1) · Martin Walter, Prof. Dr. (1) · Pravin Israel, Ph.D (1) · Samantha Meltzer-Brody, MD, MPH (1) · Sarah Bowen, PhD (1)
PMID 15850502, PMID 19032530, PMID 22439295, PMID 24647726, PMID 27920321, PMID 29540927, PMID 30538599, PMID 31304887, PMID 40779267, PMID 41950275
2019 (1), K23MH082824 (1), R01DA025764 (1), R21MH062379 (1), R42MH123357 (1)